| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC2824 |
| Trial ID | NCT05092451 |
| Disease | Myelodysplastic Syndrome | Acute Myeloid Leukemia | B-Cell Lymphoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD70 CAR-NK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances |
| Year | 2022 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2021-0386|NCI-2021-12093 |
| Cohort 1 | |||||||||
|
|||||||||